1590.2000 5.40 (0.34%)
NSE Jun 06, 2025 15:53 PM
Volume: 940.3K
 

1590.20
0.34%
Prabhudas Lilladhar
GNP sales grew 21% QoQ while it grew 10% YoY, implying seasonality benefits in key markets including India and US. Overall, its key growth came in India (15% YoY), US (15% QoQ), ROW (14% YoY) and Brazil (23%YoY). Adj. EBITDA grew 22% QoQ while on YoY basis it was flat, again it showed traditionally Q2 was strong quarter for GNP due to seasonality. While sales...
Glenmark Pharmaceuti.. has an average target of 1662.25 from 5 brokers.
More from Glenmark Pharmaceuticals Ltd.
Recommended